相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients?
Antonio Aversa et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Factors modifying the effect of blood pressure on erectile function
Paivi Elina Korhonen et al.
JOURNAL OF HYPERTENSION (2015)
Prevalence of Endocrine and Metabolic Disorders in Subjects with Erectile Dysfunction: A Comparative Study
Elisa Maseroli et al.
JOURNAL OF SEXUAL MEDICINE (2015)
A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction
Ecem Kaya et al.
JOURNAL OF SEXUAL MEDICINE (2015)
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Anindita Das et al.
PHARMACOLOGY & THERAPEUTICS (2015)
A Comprehensive Review of Erectile Dysfunction in Men with Diabetes
Z. A. Kamenov
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2015)
THERAPY OF ENDOCRINE DISEASE Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis
Daniele Santi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials
Wan Du et al.
AGING MALE (2014)
Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling
Saisudha Koka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
A Critical Analysis of the Role of Testosterone in Erectile Function: From Pathophysiology to Treatment-A Systematic Review
Andrea M. Isidori et al.
EUROPEAN UROLOGY (2014)
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
Giovanni Corona et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Alprostadil for the treatment of impotence
Vishwanath Hanchanale et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Treatment strategies for diabetic patients suffering from erectile dysfunction: an update
Grant P. Redrow et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Sexual Dysfunction at the Onset of Type 2 Diabetes: The Interplay of Depression, Hormonal and Cardiovascular Factors
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Combination of Psychological Intervention and Phosphodiesterase-5 Inhibitors for Erectile Dysfunction: A Narrative Review and Meta-Analysis
Hannah M. Schmidt et al.
JOURNAL OF SEXUAL MEDICINE (2014)
The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
Nicola Napoli et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study
D. S. Prasad et al.
OPEN HEART (2014)
Diabetic nephropathy - complications and treatment
Andy K. H. Lim
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
Endocrine evaluation of erectile dysfunction
Andrea Sansone et al.
ENDOCRINE (2014)
Avanafil for Erectile Dysfunction
Jeffrey A. Kyle et al.
ANNALS OF PHARMACOTHERAPY (2013)
The Effect of Combined Antihypertensive Treatment (Felodipine with Either Irbesartan or Metoprolol) on Erectile Function: A Randomized Controlled Trial
Longquan Yang et al.
CARDIOLOGY (2013)
An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors
Roberto Bruzziches et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice
Saisudha Koka et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Testosterone Replacement Therapy with Long-Acting Testosterone Undecanoate Improves Sexual Function and Quality-of-Life Parameters vs. Placebo in a Population of Men with Type 2 Diabetes
Geoffrey Hackett et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Which Is First? The Controversial Issue of Precedence in the Treatment of Male Sexual Dysfunctions
Emmanuele A. Jannini et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study
M. Ortac et al.
ANDROLOGY (2013)
Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches
R. A. Condorelli et al.
ANDROLOGY (2013)
Effect of Testosterone Replacement on Response to Sildenafil Citrate in Men With Erectile Dysfunction A Parallel, Randomized Trial
Matthew Spitzer et al.
ANNALS OF INTERNAL MEDICINE (2012)
A review of outcomes of an intracavernosal injection therapy programme
Peter G. Coombs et al.
BJU INTERNATIONAL (2012)
Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury
Gerry Van der Mieren et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging
Elisa Giannetta et al.
CIRCULATION (2012)
Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies
V. Phe et al.
DIABETES & METABOLISM (2012)
Intraurethral Alprostadil for Erectile Dysfunction A Review of the Literature
Pierre Costa et al.
DRUGS (2012)
Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study
Marco Guazzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Losartan improves erectile dysfunction in diabetic patients: a clinical trial
Y. Chen et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2012)
Daily Use of Sildenafil Improves Endothelial Function in Men With Type 2 Diabetes
Ling Deyoung et al.
JOURNAL OF ANDROLOGY (2012)
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction
Irwin Goldstein et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Albuminuria is an Independent Risk Factor of Erectile Dysfunction in Men with Type 2 Diabetes
Yao-Chi Chuang et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus
Irwin Goldstein et al.
MAYO CLINIC PROCEEDINGS (2012)
Erectile Dysfunction in Young Surgically Treated Patients With Lumbar Spine Disease A Prospective Follow-up Study
Mashfiqul A. Siddiqui et al.
SPINE (2012)
Efficacy and Safety of Udenafil for Erectile Dysfunction: A Meta-analysis of Randomized Controlled Trials
Hui Ding et al.
UROLOGY (2012)
Erectile Dysfunction and Hypertension: Impact on Cardiovascular Risk and Treatment
Valter Javaroni et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2012)
Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes
Karin Przyklenk et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The Effect of Lifestyle Modification and Cardiovascular Risk Factor Reduction on Erectile Dysfunction A Systematic Review and Meta-analysis
Bhanu P. Gupta et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Erectile Dysfunction A Disease Marker for Cardiovascular Disease
David Shin et al.
CARDIOLOGY IN REVIEW (2011)
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
T. Hugh Jones et al.
DIABETES CARE (2011)
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors
Robert A. Kloner et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Cardiovascular risk, drugs and erectile function - a systematic analysis
M. Baumhaekel et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Five-Item Version of the International Index of Erectile Function Correlated with Albuminuria and Subclinical Atherosclerosis in Men with Type 2 Diabetes
Michiaki Fukui et al.
Journal of Atherosclerosis and Thrombosis (2011)
The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation
Emmanuele A. Jannini et al.
JOURNAL OF SEXUAL MEDICINE (2011)
A Therapeutic Confirmatory Study to Assess the Safety and Efficacy of Zydena® (Udenafil) for the Treatment of Erectile Dysfunction in Male Patients with Diabetes Mellitus
Du Geon Moon et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Hypogonadal Men Nonresponders to the PDE5 Inhibitor Tadalafil Benefit from Normalization of Testosterone Levels with a 1% Hydroalcoholic Testosterone Gel in the Treatment of Erectile Dysfunction (TADTEST Study)
Jacques Buvat et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Effect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 Diabetes
Hunter Wessells et al.
JOURNAL OF UROLOGY (2011)
Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction
K. -E. Andersson
PHARMACOLOGICAL REVIEWS (2011)
Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials
Michael Boehm et al.
CIRCULATION (2010)
Effects of Weight Loss Intervention on Erectile Function in Older Men with Type 2 Diabetes in the Look AHEAD Trial
Rena R. Wing et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Definitions/Epidemiology/Risk Factors for Sexual Dysfunction
Ronald W. Lewis et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
Christian Gratzke et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes
Michel P. Hermans et al.
DIABETES & METABOLISM (2009)
Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients
Alin Stirban et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity
S-T Chang et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2009)
The ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction
Emmanuele A. Jannini et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Vascular Impairment of Erection in Patients with Diabetes and Peyronie's Disease: Is that Accumulative?
Ahmed I. El-Sakka et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Erectile Dysfunction in Diabetes Mellitus
Lasantha S. Malavige et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Association of Glycemic Control with Risk of Erectile Dysfunction in Men with Type 2 Diabetes
Chih-Chen Lu et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Is Type 2 Diabetes Mellitus a Cause of Severe Erectile Dysfunction in Patients With Metabolic Syndrome?
Yilmaz Aslan et al.
UROLOGY (2009)
Is erectile dysfunction a sentinel symptom for cardiovascular autonomic neuropathy in patients with type 2 diabetes?
M. Debono et al.
ANDROLOGIA (2008)
Phimosis as a presenting feature of diabetes
Stephen J. Bromage et al.
BJU INTERNATIONAL (2008)
Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus
A. Schaefer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes
A. Aversa et al.
DIABETIC MEDICINE (2008)
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction
D. Hatzichristou et al.
DIABETIC MEDICINE (2008)
Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction
A. I. El-Sakka et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2008)
Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes
Fernando Grover-Paez et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with bioavailable testosterone and visceral adiposity
Dheeraj Kapoor et al.
DIABETES CARE (2007)
Real-life safety and efficacy of vardenafil in the treatment of erectile dysfunction - Results from 30,010 US Patients
Eric Cheng
JOURNAL OF SEXUAL MEDICINE (2007)
Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study
A. Aversa et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2007)
The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus
Adel Al-Hunayan et al.
BJU INTERNATIONAL (2007)
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
M. Vardi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials
Lawrence Blonde
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction
Dan Ziegler et al.
JOURNAL OF SEXUAL MEDICINE (2006)
The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment
N. C. Pegge et al.
DIABETIC MEDICINE (2006)
Vardenal 20-mg demonstrated superior efcacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction
Nobuhisa Ishii et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Infection induced inflammation is associated with erectile dysfunction in men with diabetes
M. C. A. Blans et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries
J Buvat et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic
G Corona et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2006)
RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights
LM Jin et al.
CLINICAL SCIENCE (2006)
Controversies in Cardiology 4 - Controversies in ventricular remodelling
LH Opie et al.
LANCET (2006)
Peyronie's disease: a silent consequence of diabetes mellitus
A Tefekli et al.
ASIAN JOURNAL OF ANDROLOGY (2006)
The second princeton consensus on sexual dysfunction and cardiac risk: New guidelines for sexual medicine
G Jackson et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus
S Israilov et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2005)
Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men
O Kalter-Leibovici et al.
DIABETES CARE (2005)
High proportions of erectile dysfunction in men with the metabolic syndrome
K Esposito et al.
DIABETES CARE (2005)
Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk
GMC Rosanoa et al.
EUROPEAN UROLOGY (2005)
Ten-year incidence of self-reported erectile dysfunction in people with long-term type 1 diabetes
R Klein et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2005)
High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients
JL Weeks et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2005)
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients
C Gazzaruso et al.
CIRCULATION (2004)
Association between fasting glucose and C-reactive protein in middle-aged subjects
D Aronson et al.
DIABETIC MEDICINE (2004)
Effect of lifestyle changes on erectile dysfunction in obese men - A randomized controlled trial
K Esposito et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Physiology of erectile function
Inigo Saenz de Tejada et al.
JOURNAL OF SEXUAL MEDICINE (2004)
Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials
V Fonseca et al.
DIABETOLOGIA (2004)
Effect of antihypertensive agents on quality of life in the elderly
R Fogari et al.
DRUGS & AGING (2004)
Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction
H Padma-Nathan
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I
MA Creager et al.
CIRCULATION (2003)
Sexual function in men older than 50 years of age: Results from the health professionals follow-up study
CG Bacon et al.
ANNALS OF INTERNAL MEDICINE (2003)
Diabetic autonomic neuropathy
AI Vinik et al.
DIABETES CARE (2003)
Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: The role of the interaction between clinical and psychological factors
G De Berardis et al.
JOURNAL OF UROLOGY (2003)
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes - A multicenter double-blind placebo-controlled fixed-dose study
I Goldstein et al.
DIABETES CARE (2003)
RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum
CJ Wingard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Epidemiology of erectile dysfunction in four countries: Cross-national study of the prevalence and correlates of erectile dysfunction
A Nicolosi et al.
UROLOGY (2003)
Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus
MA Vickers et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
The neuropathy of erectile dysfunction
CB Bleustein et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
The use of treatments for erectile dysfunction among survivors of prostate carcinoma
LR Schover et al.
CANCER (2002)
Cellular basis of diabetic nephropathy II.: The transforming growth factor-β system and diabetic nephropathy lesions in type 1 diabetes
CM Huang et al.
DIABETES (2002)
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells
S Granchi et al.
MOLECULAR HUMAN REPRODUCTION (2002)
Association of type and duration of diabetes with erectile dysfunction in a large cohort of men
CG Bacon et al.
DIABETES CARE (2002)
Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes
C Desouza et al.
DIABETES CARE (2002)
Erectile dysfunction and quality of life in type 2 diabetic patients - A serious problem too often overlooked
G De Berardis et al.
DIABETES CARE (2002)
Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus
AJM Boulton et al.
DIABETOLOGIA (2001)
Diabetic impotence treated by intracavernosal injections: High treatment compliance and increasing dosage of vaso-active drugs
P Perimenis et al.
EUROPEAN UROLOGY (2001)
Neuropathy is a major contributing factor to diabetic erectile dysfunction
MJ Hecht et al.
NEUROLOGICAL RESEARCH (2001)
Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England
SAW Shakir et al.
BRITISH MEDICAL JOURNAL (2001)
Hypertension is associated with severe erectile dysfunction
M Burchardt et al.
JOURNAL OF UROLOGY (2000)
Role of brain insulin receptor in control of body weight and reproduction
JC Brüning et al.
SCIENCE (2000)
Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study
CB Johannes et al.
JOURNAL OF UROLOGY (2000)
分享论文
